{
  "trial_id": "NCT03085238",
  "trial_group": "cancer",
  "generated-by-gpt4-omni-zs": {
    "gen-response": "Age, gender, ECOG performance status, stage of ovarian cancer, type of carcinoma, residual tumor size after surgery, prior chemotherapy cycles, prior radiotherapy, concurrent medical illnesses, presence of metastases, history of other cancers, hypersensitivity to medications, concurrent use of antineoplastic agents.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "gender"
        ],
        [
          "Ovarian Cancer Stage",
          "stage of ovarian cancer"
        ],
        [
          "ECOG Performance Status",
          "ECOG performance status"
        ],
        [
          "Pregnancy",
          "gender"
        ],
        [
          "Type of debulking procedure",
          "type of carcinoma"
        ],
        [
          "Pre-debulking PCI",
          "prior chemotherapy cycles"
        ],
        [
          "Post-debulking PCI",
          "residual tumor size after surgery"
        ],
        [
          "Pre-operative serum albumin",
          "prior radiotherapy"
        ],
        [
          "Pre-operative hemoglobin",
          "concurrent medical illnesses"
        ],
        [
          "Total number of extended procedures",
          "presence of metastases"
        ]
      ],
      "remaining_reference_features": [
        "Male",
        "Race and Ethnicity Not Collected",
        "Region of Enrollment",
        "BMI"
      ],
      "remaining_candidate_features": [
        "history of other cancers",
        "hypersensitivity to medications",
        "concurrent use of antineoplastic agents."
      ]
    }
  },
  "generated-by-gpt4-omni-ts": {
    "gen-response": "Age, Continuous, Sex: Female, Race/Ethnicity, Customized, ECOG performance status, Residual tumor size post-surgery, Prior chemotherapy cycles, Histological subtype, Body Mass Index, Systolic Blood Pressure, Diastolic Blood Pressure,",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "Sex: Female"
        ],
        [
          "ECOG Performance Status",
          "ECOG performance status"
        ],
        [
          "Ovarian Cancer Stage",
          "Residual tumor size post-surgery"
        ],
        [
          "Type of debulking procedure",
          "Prior chemotherapy cycles"
        ],
        [
          "Histological subtype",
          "Histological subtype"
        ],
        [
          "BMI",
          "Body Mass Index"
        ]
      ],
      "remaining_reference_features": [
        "Male",
        "Race and Ethnicity Not Collected",
        "Region of Enrollment",
        "Pre-debulking PCI",
        "Post-debulking PCI",
        "Pre-operative serum albumin",
        "Pre-operative hemoglobin",
        "Total number of extended procedures",
        "Pregnancy"
      ],
      "remaining_candidate_features": [
        "Race/Ethnicity",
        "Systolic Blood Pressure",
        "Diastolic Blood Pressure"
      ]
    }
  },
  "generated-by-llama3-70b-in-ts": {
    "gen-response": "Age, Continuous, Sex: Female, ECOG Performance Status, Histological Type of Ovarian Cancer, Residual Tumor Size, Number of Cycles of Neoadjuvant Chemotherapy, Prior Surgery Type,",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "Sex: Female"
        ],
        [
          "ECOG Performance Status",
          "ECOG Performance Status"
        ],
        [
          "Ovarian Cancer Stage",
          "Histological Type of Ovarian Cancer"
        ],
        [
          "Type of debulking procedure",
          "Prior Surgery Type"
        ]
      ],
      "remaining_reference_features": [
        "Male",
        "Race and Ethnicity Not Collected",
        "Region of Enrollment",
        "BMI",
        "Pre-debulking PCI",
        "Post-debulking PCI",
        "Pre-operative serum albumin",
        "Pre-operative hemoglobin",
        "Total number of extended procedures",
        "Pregnancy"
      ],
      "remaining_candidate_features": [
        "Residual Tumor Size",
        "Number of Cycles of Neoadjuvant Chemotherapy"
      ]
    }
  },
  "generated-by-llama3-70b-in-zs": {
    "gen-response": "Age, ECOG performance status, Ovarian cancer stage, Histological subtype (high-grade serous carcinoma), Residual tumor size, Number of prior chemotherapy cycles, Type of debulking surgery (primary or interval), Presence of visible residual tumor, Prior abdominal and/or pelvic radiotherapy, Presence of central nervous system or cerebral metastases, History of cancer within 5 years, Presence of concurrent medical illnesses.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "Sex: Female"
        ],
        [
          "Ovarian Cancer Stage",
          "Ovarian cancer stage"
        ],
        [
          "ECOG Performance Status",
          "ECOG performance status"
        ],
        [
          "Type of debulking procedure",
          "Type of debulking surgery (primary or interval)"
        ],
        [
          "Residual tumor size",
          "Presence of visible residual tumor"
        ]
      ],
      "remaining_reference_features": [
        "Male",
        "Race and Ethnicity Not Collected",
        "Region of Enrollment",
        "BMI",
        "Pre-debulking PCI",
        "Post-debulking PCI",
        "Pre-operative serum albumin",
        "Pre-operative hemoglobin",
        "Total number of extended procedures"
      ],
      "remaining_candidate_features": [
        "Histological subtype (high-grade serous carcinoma)",
        "Number of prior chemotherapy cycles",
        "Prior abdominal and/or pelvic radiotherapy",
        "Presence of central nervous system or cerebral metastases",
        "History of cancer within 5 years",
        "Presence of concurrent medical illnesses."
      ]
    }
  }
}